Endocrinology

After years of off-label use, veterinarians now have the first FDA-approved amlodipine formulation specifically indicated for cats with systemic hypertension.

A small prospective study suggests dapagliflozin is well tolerated in dogs with heart disease and may influence oxidative biomarkers, though a clear natriuretic effect was not observed.

A research study shows that bezafibrate safely reduces canine hypertriglyceridemia by approximately 85%, even in the presence of endocrine disease.

Clinicians present research and insights for improving outcomes for patients with diabetes through diet.

Christina Gentry, DVM, DACVD, discusses concurrent diseases and skin emergencies in a dvm360 interview.

John Flanagan, PhD, presented new research at WVC 2026 that shows that a purpose-formulated, low-digestible carbohydrate diet combined with structured caloric restriction substantially increases short-term diabetic remission in overweight, insulin-treated cats.

Based on a study, John Flanagan, PhD, explains how targeted caloric restriction produced high remission rates in overweight diabetic cats and shares clinic-ready strategies for weight reduction and glycemic control.

John Flanagan, PhD, discusses his team's study that shows that a high-protein, low-digestible carbohydrate diet combined with controlled weight loss may improve diabetic remission rates in overweight cats.

John Flanagan, PhD, presented new research at WVC 2026 that shows that a purpose-formulated, low-digestible carbohydrate diet combined with structured caloric restriction substantially increases short-term diabetic remission in overweight, insulin-treated cats.

These 11 recently-released products are featured in WVC's New Product Showcase.

Royal Canin unveils a new diet for cats with diabetes and home care kits at VMX 2026.

Zygolide by Dechra offers a generic, bioequivalent option for managing pituitary pars intermedia dysfunction in horses.

Virbac acquired an oral solution of methimazole, known as Felanorm in the US and Thyronorm outside the US. The drug is the first FDA-approved generic methimazole oral solution for hyperthyroidism in cats.

Catharine Scott-Moncrieff, Vet MB, MA, MS, DACVIM-SAIM, DECVIM-CA, explains when she prescribes insulin vs SGLT2 inhibitors, how to monitor for ketosis, and which factors most influence diabetic remission in cats.

Kidogo, a 13-year-old dachshund, underwent 20 rounds of radiation treatments.

The developer of GluCurve Pet CGM anticipates a high demand for the product.

Discover the complexities of Addison's disease in dogs, including diagnosis, treatment options, and management strategies for hypoadrenocorticism.

Specific feeding instructions increase owner adherence and simplify diabetes management for dogs and cats.

A full nutrition assessment should direct therapeutic diet selection for dogs and cats with newly diagnosed diabetes.

Veterinary teams enhance feline diabetes management through personalized care, effective communication, and evolving treatment options for improved quality of life.

Feeding practices, weight management, and low-carbohydrate food choices can significantly improve long-term health and treatment outcomes for cats with diabetes.

In a series of dvm360 interviews, veterinary experts provided their insights about different aspects of the disease including treatment options, identification of the condition and treatment for it.

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM) discusses what is currently known about remission when on SGLT2 inhibitors.

An internal medicine specialist explains the answer to this question in an interview with dvm360.

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which received FDA clearance earlier this month